skip to Main Content
Texas A&M University Texas A&M Innovation recently struck a deal with BCell Solutions, Inc., a Colorado Public Benefit Corporation, to license technologies focused on CLIP modulation and use in the treatment of autoimmune and inflammatory diseases developed in the lab of Dr. M. Karen Newell-Rogers at Texas A&M’s College of Medicine. The company will use the technologies to enhance their main peptide product, furthering efforts toward development of a novel drug therapy for treatment of diseases driven by chronic inflammation and unwanted cell proliferation. We look forward to partnering with BCell Solutions to see the technologies further developed and maximize the positive impact on the public through the intended market applications. Learn more about our partner, BCell Solutions, Inc.


Media Contact: Jennifer Briggs

Back To Top